Technology

Ai2's founder, Dr Curtis Dobson, has spent over a decade at the University of Manchester studying the broad anti-infective activity of a human protein called apolipoprotein E.

Ai2 has developed a huge range of synthetic protein molecules which mimic this powerful anti-infective action, yet retain many of the natural protein's features and biocompatibility.

These "Humanized Cationic Peptides" readily absorb to a wide range of biomaterials and surfaces, providing powerful protection against common opportunistic infectious agents without risk to human tissues